Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An infection that is caused by certain species of Rickettsia or Borrelia, which are transmitted to humans from infected ticks; it is characterized by sudden fever, chills, headaches, myalgia, arthralgia, nausea, and possibly a rash. Symptoms usually persist for two to nine days, then disappear, with recurrence after several weeks if the patient remains untreated.
Biomarker and diagnostic research for tick-borne relapsing fever has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
35 publications have been identified in PubMed for tick-borne relapsing fever. Research spans Basic Science / Preclinical (37%), Epidemiology / Natural History (23%), and Case Report / Case Series (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 13 | 37% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:53 AM UTC
Disease patterns and progression |
8 |
23% |
Patient case studies | 7 | 20% |
Research summaries | 4 | 11% |
Testing and diagnosis research | 3 | 9% |
Kannai R (2026). [PMID: 41876116](https://pubmed.ncbi.nlm.nih.gov/41876116/). *Ann Fam Med*. [Case Report / Case Series]
Shwartz D (2026). [PMID: 41985201](https://pubmed.ncbi.nlm.nih.gov/41985201/). *Res Vet Sci*. [Case Report / Case Series]
Snowden J (2026). [PMID: 28722942](https://pubmed.ncbi.nlm.nih.gov/28722942/). *Unknown Journal*. [Review / Meta-Analysis]
Hernández Martínez JA (2026). [PMID: 42018570](https://pubmed.ncbi.nlm.nih.gov/42018570/). *PLoS Negl Trop Dis*. [Epidemiology / Natural History]
Pavesi A (2026). [PMID: 41974313](https://pubmed.ncbi.nlm.nih.gov/41974313/). *Travel Med Infect Dis*. [Case Report / Case Series]
Shwartz D (2026). [PMID: 42065078](https://pubmed.ncbi.nlm.nih.gov/42065078/). *Curr Res Microb Sci*. [Basic Science / Preclinical]
Bazuqamah M (2026). [PMID: 42119433](https://pubmed.ncbi.nlm.nih.gov/42119433/). *J Infect Public Health*. [Case Report / Case Series]
Shwartz D (2026). [PMID: 42116261](https://pubmed.ncbi.nlm.nih.gov/42116261/). *Emerg Infect Dis*. [Epidemiology / Natural History]
Ucciferri C (2026). [PMID: 41717054](https://pubmed.ncbi.nlm.nih.gov/41717054/). *IDCases*. [Case Report / Case Series]
Diouf C (2025). [PMID: 41768943](https://pubmed.ncbi.nlm.nih.gov/41768943/). *Medecine tropicale et sante internationale*. [Diagnostic / Biomarker]